Archives of Oral Biology
Volume 55, Issue 7 , Pages 515-522 , July 2010

The role of Desulfovibrio desulfuricans lipopolysaccharides in modulation of periodontal inflammation through stimulation of human gingival fibroblasts

  • Zofia Dzierżewicz

      Affiliations

    • Department of Biopharmacy, Medical University of Silesia, Narcyzów St. 1, 41-200 Sosnowiec, Poland
    • ,
  • Joanna Szczerba

      Affiliations

    • Department of Biopharmacy, Medical University of Silesia, Narcyzów St. 1, 41-200 Sosnowiec, Poland
    • ,
  • Jolanta Lodowska

      Affiliations

    • Department of Biochemistry, Medical University of Silesia, Narcyzów St. 1, 41-200 Sosnowiec, Poland
    • ,
  • Daniel Wolny

      Affiliations

    • Department of Biopharmacy, Medical University of Silesia, Narcyzów St. 1, 41-200 Sosnowiec, Poland
    • Corresponding Author InformationCorresponding author. Tel.: +48 323641060; fax: +48 323641060.
    • ,
  • Arkadiusz Gruchlik

      Affiliations

    • Department of Biopharmacy, Medical University of Silesia, Narcyzów St. 1, 41-200 Sosnowiec, Poland
    • ,
  • Arkadiusz Orchel

      Affiliations

    • Department of Biopharmacy, Medical University of Silesia, Narcyzów St. 1, 41-200 Sosnowiec, Poland
    • ,
  • Ludmiła Węglarz

      Affiliations

    • Department of Biochemistry, Medical University of Silesia, Narcyzów St. 1, 41-200 Sosnowiec, Poland

,Accepted 6 May 2010.

References 

  1. Dalwai F, Spratt DA, Pratten J. Modeling shifts in microbial populations associated with health or disease. Appl Environ Microbiol. 2006;72:3678–3684
  2. Handfield M, Baker H, Lamont R. Beyond goods and evil in the oral cavity: insights into host–microbe relationships derived from transcriptional profiling of gingival cells. J Dent Res. 2008;87:203–223
  3. Perea EJ. Oral flora in the age of molecular biology. Med Oral Patol Oral Cir Bucal. 2004;9(Suppl. 6–10):1–5
  4. Liébana J, Castillo AM, Alvarez M. Periodontal diseases: microbiological considerations. Med Oral Patol Oral Cir Bucal. 2004;9(Suppl. 82–91):75–82
  5. Van Dyke TE, Sheilesh D. Risk factors for periodontitis. J Int Acad Periodontol. 2005;7:3–7
  6. Loubinoux J, Mory F, Pereira IA, Le Faou AE. Bacteremia caused by a strain of Desulfovibrio related to the provisionally named Desulfovibrio fairfieldensis. J Clin Microbiol. 2000;38:931–934
  7. Loubinoux J, Bisson-Boutelliez C, Miller N, Le Faou AE. Isolation of the provisionally named Desulfovibrio fairfieldensis from human periodontal pockets. Oral Microbiol Immunol. 2002;17:321–323
  8. Langendijk PS, Hagemann J, van der Hoeven JS. Sulfate-reducing bacteria in periodontal pockets and in healthy oral sites. J Clin Periodontol. 1999;26:596–599
  9. Langendijk PS, Hanssen JT, Van der Hoeven JS. Sulfate-reducing bacteria in association with human periodontitis. J Clin Periodontol. 2000;27:943–950
  10. Langendijk PS, Kulik EM, Sandmeier H, Meyer J, van der Hoeven JS. Isolation of Desulfomicrobium orale sp. nov. and Desulfovibrio strain NY682, oral sulfate-reducing bacteria involved in human periodontal disease. Int J Syst Evol Microbiol. 2001;51:1035–1044
  11. Langendijk-Genevaux PS, Hanssen JT, van der Hoeven JS. Decrease of sulfate-reducing bacteria after initial periodontal treatment. J Dent Res. 2001;80:1637–1642
  12. Langendijk-Genevaux PS, Grimm WD, van der Hoeven JS. Sulfate-reducing bacteria in relation with other potential periodontal pathogens. J Clin Periodontol. 2001;28:1151–1157
  13. Boopathy R, Robichaux M, LaFont D, Howell M. Activity of sulfate-reducing bacteria in human periodontal pocket. Can J Microbiol. 2002;48:1099–1103
  14. Robichaux M, Howell M, Boopathy R. Growth and activities of sulfate-reducing and methanogenic bacteria in human oral cavity. Curr Microbiol. 2003;47:12–16
  15. Van der Hoeven JS, van den Kieboom CW, Schaeken MJ. Sulfate-reducing bacteria in the periodontal pocket. Oral Microbiol Immunol. 1995;10:288–290
  16. Vianna ME, Holtgraewe S, Seyfarth I, Conrads G, Horz HP. Quantitative analysis of three hydrogenotrophic microbial groups, methanogenic archaea, sulfate-reducing bacteria, and acetogenic bacteria, within plaque biofilms associated with human periodontal disease. J Bacteriol. 2008;190:3779–3785
  17. Goldstein EJC, Citron DM, Peraino VA, Cross SA. Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections. J Clin Microbiol. 2003;41:2752–2754
  18. Schoenborn L, Abdollahi H, Tee W, Dyall-Smith M, Janssen PH. A member of delta subgroup of Proteobacteria from a pyogenic liver abscess is a typical sulfate reducer of the genus Desulfovibrio. J Clin Microbiol. 2001;39:787–790
  19. Loubinoux J, Bronowicki JP, Pereira IAC, Mougenel JL, Le Faou AE. Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol Ecol. 2002;40:107–112
  20. Postgate JR. The sulphate reducing bacteria. Cambridge Univ. Press; 1984;
  21. Boyle A, Phelps CD, Young LY. Isolation from estaurine sediments of Desulfovibrio strain which can grow on lactate coupled to the reductive dehalogenation of 2,4,6-tribromophenol. Appl Environ Microbiol. 1999;65:1133–1140
  22. Nercessian O, Bienvenu N, Moreira D, Prieur D, Jeanthon C. Diversity of functional genes of methanogens, methanotrophs and sulfate reducers in deep-sea hydrothermal environments. Environ Microbiol. 2005;7:118–132
  23. Shukla SK, Reed KD. Desulfovibrio desulfuricans bacteremia in a dog. J Clin Microbiol. 2000;38:1701–1702
  24. Irie K, Ekuni D, Yamamoto T, Morita M, Yaegaki K, Ii H, et al. A single application of hydrogen sulphide induces a transient osteoclast differentiation with RANKL expression in the rat model. Arch Oral Biol. 2009;54:723–729
  25. Hughes FJ, McNab R. Oral malodour—a review. Arch Oral Biol. 2008;53(Suppl. 1):S1–S7
  26. Siqueira JF, Rôças IN. Bacterial pathogenesis and mediators in apical periodontitis. Braz Dent J. 2007;18:267–280
  27. Ren L, Jin L, Leung WK. Local expression of lipopolysaccharide-binding protein in human gingival tissues. J Periodontal Res. 2004;39:242–248
  28. Ren L, Jiang ZQ, Fu Y, Leung WK, Jin L. The interplay of lipopolysaccharide-binding protein and cytokines in periodontal health and disease. J Clin Periodontol. 2009;36:619–626
  29. Niederman R, Buyle-Bodin Y, Lu BY, Naleway C, Robinson P, Kent R. The relationship of gingival crevicular fluid short chain carboxylic acid concentration to gingival inflammation. J Clin Periodontol. 1996;23:743–749
  30. Niederman R, Buyle-Bodin Y, Lu BY, Robinson P, Naleway C. Short-chain carboxylic acid concentration in human gingival crevicular fluid. J Dent Res. 1997;76:575–579
  31. Pöllänen M, Salonen J. Effect of short chain fatty acids on human gingival epithelial cell keratins in vitro. Eur J Oral Sci. 2000;108:523–529
  32. Dzierżewicz Z, Cwalina B, Gawlik B, Wilczok T, Gonciarz Z. Isolation and evaluation of susceptibility to sulphasalazine of Desulfovibrio desulfuricans strains from the human digestive tract. Acta Microbiol Pol. 1997;46:175–187
  33. Johnson KG, Perry MB. Improved techniques for the preparation of bacterial lipopolysaccharides. Can J Microbiol. 1975;22:29–34
  34. Lawden KH, Pitts JM, Thomas JA, Lowe CR. Rational computer-aided design of ligands that bind endotoxin. In:  Levin J,  Alving CR,  Munford RS,  Redl H editor. Bacterial endotoxins: lipopolysaccharides from genes to therapy. Wiley-Liss, Inc.; 1995;p. 443–452
  35. Węglarz L, Dzierżewicz Z, Orchel A, Szczerba J, Jaworska-Kik M, Wilczok T. Biological activity of Desulfovibrio desulfuricans lipopolysaccharides evaluated via interleukin-8 secretion by Caco-2 cells. Scand J Gastroenterol. 2003;38:73–79
  36. Wilson M. Biological activities of lipopolysaccharides from oral bacteria and their relevance to the pathogenesis of chronic periodontitis. Sci Prog. 1995;78:19–34
  37. Ren L, Leung WK, Loo TW, Jin L. Lipopolysaccharide-binding protein down-regulates the expression of interleukin-6 by human gingival fibroblast. J Periodontal Res. 2005;40:407–416
  38. Xiao Y, Bunn CL, Bartold PM. Effect of lipopolysaccharide from periodontal pathogens on the production of tissue plasminogen activator and plasminogen activator inhibitor 2 by human gingival fibroblasts. J Periodontal Res. 2001;36:25–31
  39. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res. 1991;26:230–242
  40. Takashiba S, Naruishi K, Murayama Y. Perspective of cytokine regulation for periodontal treatment: fibroblast biology. J Periodontol. 2003;74:103–110
  41. Wang PL, Ohura K. Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and Toll-like receptors. Crit Rev Oral Biol Med. 2002;13:132–142
  42. Wang PL, Shirasu S, Shinohar M, Azuma Y, Daito M, Yasuda H, et al. IL-10 inhibits Porphyromonas gingivalis LPS-stimulated human gingival fibroblasts production of IL-6. Biochem Biophys Res Commun. 1999;263:372–377
  43. Kent LW, Rahemtulla F, Michalek SM, Interleukin . (IL)-1 and Porphyromonas gingivalis lipopolysaccharide stimulation of IL-6 production by fibroblasts derived from healthy or periodontally diseased human gingival tissue. J Periodontol. 1999;70:274–282
  44. Dongari-Bagtzoglou AI, Ebersole JL. Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J Periodontal Res. 1996;31:90–98
  45. Chou HH, Takashiba S, Maeda H, Naruishi K, Nishimura F, Arai H, et al. Induction of intracellular interleukin-1 beta signals via type II interleukin-1 receptor in human gingival fibroblasts. J Dent Res. 2000;79:1683–1688
  46. Phipps RP, Borrello MA, Blieden TM. Fibroblast heterogeneity in the periodontium and other tissues. J Periodontal Res. 1997;32:159–165
  47. Agarwal S, Baran C, Piesco NP, Quintero JC, Langkamp HH, Johns LP, et al. Synthesis of proinflammatory cytokines by human gingival fibroblasts in response to lipopolysaccharides and interleukin-1 beta. J Periodontal Res. 1995;30:382–389
  48. Huang Y, Li N, Liboni K, Neu J. Glutamine decreases lipopolysaccharide-induced IL-8 production in Caco-2 cells through a non-NF-kappaB p50 mechanism. Cytokine. 2003;22:77–83
  49. Eskan MA, Benakanakere MR, Rose BG, Zhang P, Zhao J, Stathopoulou P, et al. Interleukin-1β modulates proinflammatory cytokine production in human epithelial cells. Infect Immun. 2008;76:2080–2089
  50. Kurita-Ochiai T, Fukushima K, Ochiai K. Butyric acid-induced apoptosis of murine thymocytes, splenic T cells, and human Jurkat T cells. Infect Immun. 1997;65:35–41
  51. Kurita-Ochiai T, Ochiai K, Suzuki N, Otsuka K, Fukushima K. Human gingival fibroblasts rescue butyric acid-induced T-cell apoptosis. Infect Immun. 2002;70:2361–2367

PII: S0003-9969(10)00119-6

doi: 10.1016/j.archoralbio.2010.05.001

Archives of Oral Biology
Volume 55, Issue 7 , Pages 515-522 , July 2010

Article Tools

* Image Usage & Resolution